Global Clinical Laboratory Services – Services
Read the full report: http://www.reportlinker.com/p04707129-summary/view-report.html
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 131 companies including many key and niche players such as:
-
-
-
- Bioscientia Institut für
- DaVita, Inc.
Read the full report: http://www.reportlinker.com/p04707129-summary/view-report.html
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW.............. II-1 Outlook.............. II-1 Developed Nations: Cost Pressures Necessitate New Strategies II-2 Despite Challenges, Emerging Markets Provide Growth Opportunities.............. II-3 Routine Testing Take the Lead; Esoteric Testing Services Drive Growth.............. II-3 Common Routine and Esoteric Tests II-4
Table 2: Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart) II-7
Table 3: Life Expectancy for Select Countries in Number of Years: 2015E (includes corresponding Graph/Chart) II-8 Increase in Healthcare Spending in Emerging Markets II-9 Table 4: Healthcare Spending as a Percentage of GDP by Region (2016E) (includes corresponding Graph/Chart) II-10
Table 5: Per-Capita Healthcare Expenditure in US$ for Select Countries/Regions (2014) (includes corresponding Graph/Chart).............. II-10 Increasing Awareness Levels..............II-11 Need to Cut Healthcare Costs..............II-11 Rising Incidence of Diseases..............II-11 Major Causes of Fatalities Worldwide II-11 Table 6: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart) II-11
Table 7: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart).............. II-12
Table 8: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart).............. II-13 World Cancer Statistics: Incidence and Mortality Data II-14 Table 9: World Cancer Incidence by
Table 10: World Cancer Mortality by
Table 11: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart) II-16
Table 12: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)..............II-16
Table 13: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart) II-17
Table 14: Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart)..............II-17
Table 15: Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver (includes corresponding Graph/Chart)..............II-18 Cancer Prone Sites based on Age II-18 Global HIV Statistics..............II-18 Table 16: HIV Infection Statistics Worldwide: As of 2014 (includes corresponding Graph/Chart) II-18
Table 17: Worldwide HIV Prevalence and Incidence (in Million) by Region: 2014 (includes corresponding Graph/Chart).............. II-19
Table 18: Worldwide AIDS Related Deaths by
Table 19: HIV-Positive Individuals, by Gender (2014): Percentage Breakdown of Women and Men Tested HIV-Positive in all WHO Regions (includes corresponding Graph/Chart) II-20 Cardiovascular Disease Statistics II-21 Table 20: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart).............. II-21
Table 21: Prevalence of Heart Failure in Select Countries (includes corresponding Graph/Chart) II-21
Table 22: Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025, and 2030 (includes corresponding Graph/Chart).............. II-22 Increasing Role of
2. MARKET TRENDS & ISSUES..............II-24 IVD Market Growth: An Indication of Growth in Clinical Labs Market.............. II-24 New Technologies and Tests Drive Demand for Specific Testing II-24 Increasing Role of Advanced Tests in Clinical Treatment Decision Making.............. II-24 Increasing Opportunities in Personalized Medicine and Clinical Trial Services.............. II-25 Cancer Testing Market: Opportunity for Clinical Labs II-25 Shortened Hospitalization Enhances Significance of Medical Labs II-26 Lab Automation Speeds Up..............II-26 Standardization Gains Precedence in the Hunt for Automation II-26 Heightened Use of IT Systems in Clinical Laboratories II-27 Assessing the Impact of Point-of-Care Testing on Clinical Labs II-27 Autoimmune Disease Testing: Labs Seek Cost-Effective & High Productivity Options..............II-28 POLs: Reducing Turnaround Times for Testing II-29 POL Market Succumbs to Cost Pressures II-29 Laboratory Outsourcing Trend Gains Strength II-30 Value-Based Outsourcing of Services to Take Centerstage II-30 Challenges Facing Lab Testing Market II-31
3. COMPETITIVE LANDSCAPE..............II-32 A Preview..............
4. CLINICAL LABORATORY SERVICES - AN INTRODUCTION II-37 Clinical Laboratory Services..............II-37 What is a
5. SERVICE/PRODUCT INTRODUCTIONS..............II-51 Quest Diagnostics Introduces Antibody Test for Zika Virus II-51 Mayo Clinic Launches Zika Antibody Test II-51 Quest Diagnostics Introduces CogniSense™ Cognitive Assessment Tool.............. II-51 Great Basin Scientific Launches Shiga Toxin Direct Test II-51 Laboratory Corporation of America Launches Zika Virus Testing II-51 Quest Diagnostics Introduces New Cancer Test Services II-51 Laboratory Corporation of America Launches Epi proColon® Colorectal Cancer Test..............II-52 Immunetics to Launch New Services for Invasive Fungal Infections II-52 Unilabs Launches Zika Virus Test II-52 NeoGenomics Adds Two New Tests to its Biopsy Testing Menu II-52 Quest Diagnostics Launches New Test for NSCLC II-52 MDxHealth Introduces SelectMDx™ Test for Prostate Cancer II-52 NeoGenomics Expands its FISG Testing Repertoire with NeoSITE™ II-52 Commonwealth Laboratories Launches IBSchek Blood Test for
6. RECENT INDUSTRY ACTIVITY..............II-54 Sysmex Inks Agreement with
7. FOCUS ON SELECT PLAYERS..............
8. GLOBAL MARKET PERSPECTIVE..............II-70 Table 23: World Recent Past, Current and Future Analysis for Clinical Laboratory Services by
Table 24: World Historic Review for Clinical Laboratory Services by
Table 25: World 14-Year Perspective for Clinical Laboratory Services by
Table 26: World Recent Past, Current and Future Analysis for
Table 27: World Historic Review for
Table 28: World 14-Year Perspective for
Table 29: World Recent Past, Current and Future Analysis for
Table 30: World Historic Review for
Table 31: World 14-Year Perspective for
Table 32: World Recent Past, Current and Future Analysis for
Table 33: World Historic Review for
Table 34: World 14-Year Perspective for
III. MARKET
1.
Table 43: Closed M&A Transactions in the US Clinical Labs Market (2009-2013): Breakdown by
Table 45:
Table 48: US Historic Review for Clinical Laboratory Services by Location -
Table 49: US 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
2.
Table 51: New Cancer Cases in
Table 52: Cancer Incidence in
Table 54: Canadian Historic Review for Clinical Laboratory Services by Location -
Table 55: Canadian 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
3.
Table 59: Japanese Historic Review for Clinical Laboratory Services by Location -
Table 60: Japanese 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
4.
Table 64: European Historic Review for Clinical Laboratory Services by
Table 65: European 14-Year Perspective for Clinical Laboratory Services by
Table 66: European Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location -
Table 67: European Historic Review for Clinical Laboratory Services by Location -
Table 68: European 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
4a.
Table 72: French Historic Review for Clinical Laboratory Services by Location -
Table 73: French 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
4b.
Table 75: German Historic Review for Clinical Laboratory Services by Location -
Table 76: German 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
4c.
Table 78: Italian Historic Review for Clinical Laboratory Services by Location -
Table 79: Italian 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
4d. THE UNITED KINGDOM..............III-95 A.Market Analysis.............. III-95 Outlook.............. III-95 UKAS - The Sole National Accreditation Body in the
Table 81:
Table 82:
4e.
Table 84: Spanish Historic Review for Clinical Laboratory Services by Location -
Table 85: Spanish 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
4f.
Table 87: Russian Historic Review for Clinical Laboratory Services by Location -
Table 88: Russian 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
4g. REST OF
Table 90: Rest of Europe Historic Review for Clinical Laboratory Services by Location -
Table 91: Rest of
5.
Table 93: Asia-Pacific Historic Review for Clinical Laboratory Services by
Table 94:
Table 95: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location -
Table 96: Asia-Pacific Historic Review for Clinical Laboratory Services by Location -
Table 97:
5a.
Table 100: Chinese Historic Review for Clinical Laboratory Services by Location -
Table 101: Chinese 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
5b. REST OF
Table 105: Rest of Asia-Pacific Historic Review for Clinical Laboratory Services by Location -
Table 106: Rest of
6.
Table 108: Latin American Historic Review for Clinical Laboratory Services by Location -
Table 109: Latin American 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
7. REST OF WORLD.............. III-147 A.Market Analysis.............. III-147 Outlook..............
Table 111: Rest of World Historic Review for Clinical Laboratory Services by Location -
Table 112: Rest of World 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 131 (including Divisions/Subsidiaries - 143)
Read the full report: http://www.reportlinker.com/p04707129-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-clinical-laboratory-services---services-300410322.html
SOURCE Reportlinker
Community Health Systems, Inc. Announces Fourth Quarter and Year-End 2016 Results and 2017 Guidance
Medicaid expansion falls in Kansas House panel, likely done for year
Advisor News
- Millennials are inheriting billions and they want to know what to do with it
- What Trump Accounts reveal about time and long-term wealth
- Wellmark still worries over lowered projections of Iowa tax hike
- Wellmark still worries over lowered projections of Iowa tax hike
- Could tech be the key to closing the retirement saving gap?
More Advisor NewsAnnuity News
- How to elevate annuity discussions during tax season
- Life Insurance and Annuity Providers Score High Marks from Financial Pros, but Lag on User Friendliness, JD Power Finds
- An Application for the Trademark “TACTICAL WEIGHTING” Has Been Filed by Great-West Life & Annuity Insurance Company: Great-West Life & Annuity Insurance Company
- Annexus and Americo Announce Strategic Partnership with Launch of Americo Benchmark Flex Fixed Indexed Annuity Suite
- Rethinking whether annuities are too late for older retirees
More Annuity NewsHealth/Employee Benefits News
- Trump's Medicaid work mandate could kick thousands of homeless Californians off coverage
- Confidence is the new workplace currency
- Governor signs education package on reading, math, teacher benefits
- Findings from Belmont University College of Pharmacy Provide New Insights into Managed Care and Specialty Pharmacy (Comparing rates of primary medication nonadherence and turnaround time among patients at a health system specialty pharmacy …): Drugs and Therapies – Managed Care and Specialty Pharmacy
- Study Data from Ohio State University Update Knowledge of Managed Care (Preventive Care Utilization, Employer-sponsored Benefits, and Influences On Utilization By Healthcare Occupational Groups): Managed Care
More Health/Employee Benefits NewsLife Insurance News
- Kansas City Life: Q4 Earnings Snapshot
- Gulf Guaranty Life Insurance Company Trademark Application for “OPTIBEN” Filed: Gulf Guaranty Life Insurance Company
- Marv Feldman, life insurance icon and 2011 JNR Award winner, passes away at 80
- Continental General Partners with Reframe Financial to Bring the Next Evolution of Reframe LifeStage to Market
- ASK THE LAWYER: Your beneficiary designations are probably wrong
More Life Insurance News